Isolation and chatacterization of homoisoflavonoids from Dracaena cochinchinensis and their osteogenic activities in mouse mesenchymal stem cells
- 1 September 2016
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 129, 466-472
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Natural Science Foundation (LQ16H280001)
- China Postdoctoral Science Foundation (2015M571947)
- Zhejiang Postdoctoral Science Foundation (BSH1502109)
- Lishui High-level Talents (2015RC21)
- Shanghai Municipal Health Bureau young scientific research (20154Y0005)
This publication has 18 references indexed in Scilit:
- Isolation of Antiosteoporotic Compounds from Seeds of Sophora japonicaPLOS ONE, 2014
- Antioxidant Phenolic Compounds of Dracaena CambodianaMolecules, 2010
- Rapamycin Promotes the Osteoblastic Differentiation of Human Embryonic Stem Cells by Blocking the mTOR Pathway and Stimulating the BMP/Smad PathwayStem Cells and Development, 2010
- Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapiesMechanisms of Ageing and Development, 2008
- Dragon's blood: Botany, chemistry and therapeutic usesJournal of Ethnopharmacology, 2008
- Flavonoids from the Resin of Dracaena cochinchinensisHelvetica Chimica Acta, 2004
- Control of osteoblast function and regulation of bone massNature, 2003
- A Small Molecule with Osteogenesis-Inducing Activity in Multipotent Mesenchymal Progenitor CellsJournal of the American Chemical Society, 2002
- Age-Related Osteogenic Potential of Mesenchymal Stromal Stem Cells from Human Vertebral Bone MarrowJournal of Bone and Mineral Research, 1999
- OSTEOPOROSISEndocrinology and Metabolism Clinics of North America, 1997